查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466126

细胞治疗技术市场：按产品、製程、细胞类型和最终用户 - 2024-2030 年全球预测

Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Process (Cell Preservation, Distribution, & Handling, Cell Processing, Process Monitoring & Quality Control), Cell Type, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年细胞治疗技术市场规模为194.8亿美元，预计2024年将达223.1亿美元，2030年将达506.9亿美元，复合年增长率为14.63%。

细胞治疗技术市场包括用于治疗目的的细胞疗法的研究、开发、生产和应用的产品、服务和技术。这包括广泛的产品，例如消耗品（试剂、酵素、培养基）、设备（培养箱、离心机）和服务（细胞疗法製造）。该领域主要由再生医学和免疫疗法的进步推动，再生医学和免疫疗法的重点是修復和替换受损的组织和细胞，以治疗各种疾病和病症。细胞治疗技术应用于多个领域，包括肿瘤学、心血管疾病治疗、整形外科治疗、自体免疫疾病管理、遗传性遗传疾病矫正等。癌症、糖尿病和心血管疾病等慢性疾病的全球负担日益增加，加速了对创新治疗方法的需求。此外，政府机构和私人投资者的有利资金筹措方案正在增加对细胞疗法开发相关研究活动的投资。然而，细胞疗法的开发和生产通常需要复杂的步骤，导致相关成本高昂，并限制了可负担性和可用性。技术纯熟劳工的短缺会影响业界的进步速度。为了克服这些挑战，生物製药公司和研究机构之间的策略联盟正在迅速扩大。该行业可以透过利用人工智慧 (AI) 和机器学习 (ML) 来优化流程、确定细胞治疗的新标靶以及利用 3D 生物列印来进一步扩大其影响范围。

主要市场统计
基准年[2023] 194.8亿美元
预测年份 [2024] 223.1亿美元
预测年份 [2030] 506.9亿美元
复合年增长率（%） 14.63%

产品巨量资料分析工具的出现推动了细胞治疗软体工具的采用

耗材是细胞治疗各阶段所需的关键组件，包括细胞分离、扩增、分化和储存。主要消耗品包括试剂、培养基、血清、生长因子和维持最佳细胞生长条件所需的其他补充品。细胞治疗技术中使用的设备包括在将细胞施用给患者之前用于分离、精製、扩增、分化和基因修饰细胞的设备。此类别包括反应器（一次性或可重复使用）、离心机（用于根据密度分离细胞）和流式细胞仪（用于识别不同类型的细胞）。细胞治疗耗材和设备使科学家能够在培养物中培养新细胞，用于药物开发目的。软体解决方案对于有效管理、分析和解释细胞治疗过程中产生的资料至关重要。这些软体工具有助于监控品管参数、分析资料和预测治疗结果。

过程细胞保存技术的进展

细胞保存对于在储存和运输过程中维持细胞活力和功能至关重要。保存方法（冷冻保存、玻璃化等）和培养基选择根据细胞类型和目的而变化。细胞加工涉及从骨髓和脂肪组织等各种来源分离、修饰和富集治疗细胞。此步骤对于实现所需的治疗效果同时最大限度地减少移植后副作用至关重要。过程监控可确保在整个製造过程中保持关键的品质属性，以满足细胞治疗方法的监管要求。品管对于评估最终治疗产品并确保其安全性、有效性和纯度至关重要。

细胞类型 扩大人类细胞在细胞和基因治疗的用途

动物细胞广泛应用于多种研究领域，包括药物发现、疾病建模、毒理学研究和基础科学研究。动物细胞是研究细胞过程和理解复杂生物系统的宝贵工具。此外，动物细胞在生产治疗药物重组蛋白的生物过程中扮演重要角色。由于干细胞研究和再生医学的进步，人类细胞在治疗中的使用显着增加。人源细胞已成为个人化医疗方法的重要工具，透过根据其独特的基因组成针对特定的患者特征来治疗和预防疾病。

政府鼓励对最终用户研究机构投资的倡议

在医疗保健和生命科学领域，个人化医疗、再生医学以及改善患者治疗效果的持续努力等因素正在推动对细胞治疗技术的需求。这些技术包括用于分离、扩增、分析、储存和运输细胞的复杂设备和消耗品。基于医疗保健和生命科学机构需求的偏好从临床级试剂到高效的细胞培养系统，可促进细胞快速生长，同时保持高品质标准。该研究所主要致力于了解细胞过程、识别新的治疗标靶以及开发利用细胞治疗技术治疗疾病的创新方法。他们的需求包括最先进的分析和数位工具，可以准确洞察各种条件下的细胞行为。

区域洞察

美国和加拿大是美洲细胞治疗技术发展的主要贡献者。这里有完善的生物技术和製药产业，许多研究机构都在促进该领域的创新。美国在细胞治疗创新相关专利申请数量方面处于领先地位，这正在推动私人和公共机构的投资。此外，政府推动肿瘤学和遗传疾病研究的措施和资金正在加速基因和细胞治疗技术的发展。在欧洲，注重研发的欧盟国家在细胞治疗技术市场中处于领先地位。多家欧洲生物技术公司在先进治疗药物（ATMP）的临床试验中取得了巨大成功。在亚太地区，中国、日本和印度是细胞治疗技术成长最快的市场。中国已成为主要参与者，对专门从事细胞治疗的生物技术公司进行了大量投资。中国的监管改革加快了临床试验的核准流程，并促进了细胞疗法的快速商业化。日本在再生医学研究方面的领先地位很大程度上得益于政府对该领域的积极支持。

FPNV定位矩阵

FPNV定位矩阵对于评估细胞治疗技术市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对细胞治疗技术市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.细胞治疗技术市场的市场规模与预测是多少？

2.在细胞治疗技术市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.细胞治疗技术市场的技术趋势与法规结构是什么？

4.细胞治疗技术市场主要厂商的市场占有率为何？

5. 进入细胞治疗技术市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球慢性病和感染疾病的发生率正在增加
      • 增加细胞疗法生产设施的 GMP 认证
      • 政府大力投资细胞研究
    • 抑制因素
      • 与细胞治疗技术相关的高成本
    • 机会
      • 持续关注个人化医疗
      • iPSC 的出现作为 ES 细胞的技术替代品
    • 任务
      • 缺乏熟练的专业人员和严格的法规结构
  • 市场区隔分析
    • 产品：巨量资料分析工具的出现将推动细胞治疗软体工具的采用
    • 过程：细胞保存技术的进步
    • 细胞类型：人类细胞在细胞和基因治疗中的使用越来越多
    • 最终用户：政府鼓励对研究机构投资的倡议
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章细胞治疗技术市场：副产品

  • 消耗品
  • 装置
  • 软体

第七章细胞治疗技术市场：依製程分类

  • 细胞储存、分配和处理
  • 细胞处理
  • 过程监控和品管

第八章按细胞类型分類的细胞治疗技术市场

  • 动物细胞
  • 人体细胞

第九章细胞治疗技术市场：依最终用户分类

  • 医疗保健和生命科学
  • 调查机构

第十章美洲细胞治疗技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太细胞治疗技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲细胞治疗技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Clade Therapeutics 宣布收购 Gadeta BV
    • 投资者投资细胞疗法生产，Start-UpsCerales 增资 2.55 亿美元
    • NewBiologix 筹集了 5000 万美元，用于推进基因和细胞疗法製造的新技术平台
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-034230D3E636

[188 Pages Report] The Cell Therapy Technologies Market size was estimated at USD 19.48 billion in 2023 and expected to reach USD 22.31 billion in 2024, at a CAGR 14.63% to reach USD 50.69 billion by 2030.

The cell therapy technologies market encompasses the products, services, and techniques employed in the research, development, production, and application of cellular therapies for therapeutic purposes. This includes a wide range of products such as consumables (reagents, enzymes, media), equipment (incubators, centrifuges), and services (cell therapy manufacturing). The field is primarily driven by advancements in regenerative medicine and immunotherapies that focus on repairing or replacing damaged tissue or cells to treat various diseases and disorders. Cell therapy technologies find applications in multiple areas such as oncology, cardiovascular disease treatment, orthopedic treatments, autoimmune disorders management, and inherited genetic disorders correction. The increasing global burden of chronic diseases such cancer, diabetes and cardiovascular disorders has accelerated the demand for innovative therapies. Additionally, favorable funding scenarios from government agencies and private investors have led to increased investments in research activities related to cell therapy development. However, the development and production of cell therapies often require complex procedures, which result in high associated costs, limiting their affordability and accessibility. A dearth of skilled workers may affect the rate at which advancements are made within the industry. Strategic alliances among biopharmaceutical companies and research institutes are rapidly expanding to overcome such challenges. Leveraging artificial intelligence (AI) and machine learning (ML) to optimize processes or identify new targets for cellular therapies and utilization of 3D bioprinting can further expand the scope of the industry.

KEY MARKET STATISTICS
Base Year [2023] USD 19.48 billion
Estimated Year [2024] USD 22.31 billion
Forecast Year [2030] USD 50.69 billion
CAGR (%) 14.63%

Product: The advent of big data analytics tools driving the adoption of software tools for cell therapies

Consumables are essential components required during the various stages of cell therapy procedures, such as cell isolation, expansion, differentiation, and preservation. Key consumables include reagents, media, sera, growth factors, and other supplements needed to maintain optimal cell growth conditions. Equipment used in cell therapy technologies includes devices for isolation, purification, expansion, differentiation, or genetic modification of cells before administering them to patients. This category comprises bioreactors (single-use or reusable), centrifuges (for separating cells based on density), and flow cytometers (for identifying different types of cells). Cell therapy consumables and equipment enable scientists to grow new cells in the culture media for the purpose of drug development. Software solutions are critical to the effective management, analysis, and interpretation of data generated during cell therapy procedures. These software tools assist in monitoring quality control parameters, data analysis, and predicting treatment outcomes.

Process: Advancements in cell preservation technologies

Cell preservation is vital for maintaining the viability and functionality of cells during storage and transportation. The selection of preservation methods (such as cryopreservation or vitrification) and media depends on the cell type and intended application. Cell processing involves the isolation, modification, and concentration of therapeutic cells from various sources, such as bone marrow or adipose tissue. This step is crucial for achieving desired therapeutic effects while minimizing adverse reactions post-transplantation. Process monitoring ensures that critical quality attributes are maintained throughout manufacturing processes to meet regulatory requirements for cell-based therapies. Quality control is critical for evaluating the final therapeutic product and ensuring its safety, efficacy, and purity.

Cell type: Rising utilization of human cells in cell and gene therapies

Animal cells are widely used in various research areas, including drug discovery, disease modeling, toxicology studies, and basic science research. They serve as valuable tools in studying cellular processes and understanding complex biological systems. Moreover, animal cells play a significant role in bioprocessing for the production of recombinant proteins for therapeutics. The use of human cells in therapy has increased significantly due to advancements in stem cell research and regenerative medicine. Human-derived cells have become essential tools for personalized medicine approaches that aim to treat or prevent diseases by targeting specific patient profiles based on their unique genetic makeup.

End user: Government initiatives to propel investments in research institutes

In the healthcare and life science sector, the need for cell therapy technologies has been increasing due to factors such as personalized medicine, regenerative medicine, and the ongoing drive to improve patient outcomes. These technologies include advanced equipment and consumables used in cell isolation, expansion, analysis, storage, and transportation. Need-based preferences for healthcare and life science organizations range from clinical-grade reagents to efficient cell culture systems that promote rapid cell growth while maintaining high-quality standards. Research institutes primarily focus on understanding cellular processes, identifying new therapeutic targets, and developing innovative approaches for disease treatment using cell therapy technologies. Their needs include cutting-edge analytical and digital tools that provide accurate insights into cellular behavior under various conditions.

Regional Insights

The United States and Canada are major contributors to the growth of cell therapy technologies in the Americas. The presence of established biotechnology and pharmaceutical industries, along with numerous research institutions, drives innovation in this sector. The U.S. leads in patents filed for cell therapy innovations, which encourages investments from private and public entities. Furthermore, government initiatives and funding to propel research for oncology and genetic diseases have accelerated the development of gene and cell therapy technologies. In Europe, the European Union (EU) countries lead the market for cell therapy technologies with a strong focus on research and development. Several European biotech firms have made significant progress in clinical trials for advanced therapeutic medicinal products (ATMPs). China, Japan, and India are fast-growing markets for cell therapy technologies within the Asia Pacific region. China has established itself as a major player due to its considerable investment in biotech companies focused on cellular therapies. Chinese regulatory reforms have expedited approval processes for clinical trials, enabling rapid commercialization of cell therapies. Japan leads in regenerative medicine research primarily because of its government's proactive support for the sector.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Therapy Technologies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Therapy Technologies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Technologies Market, highlighting leading vendors and their innovative profiles. These include Anterogen Co., Ltd., Atara Biotherapeutics by FUJIFILM Corporation, Athersys, Inc., Becton, Dickinson and Company, Bluebird Bio, Inc., Bristol-Myers Squibb Company, Cellectis SA, Danaher Corporation, ElevateBio, Gamida Cell, GE Healthcare, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novartis AG, Sartorius AG, STEMCELL Technologies Inc., Takeda Pharmaceutical Company Limited, Tego Science, Terumo Bct, Inc., Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
    • Equipment
      • Cell Processing Equipment
      • Single-Use Equipment
    • Software
  • Process
    • Cell Preservation, Distribution, & Handling
    • Cell Processing
    • Process Monitoring & Quality Control
  • Cell Type
    • Animal Cells
    • Human Cells
      • Differentiated Cells
      • Stem Cells
  • End-User
    • Healthcare & Life Science
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Therapy Technologies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Therapy Technologies Market?

3. What are the technology trends and regulatory frameworks in the Cell Therapy Technologies Market?

4. What is the market share of the leading vendors in the Cell Therapy Technologies Market?

5. Which modes and strategic moves are suitable for entering the Cell Therapy Technologies Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of chronic diseases and infections globally
      • 5.1.1.2. Rising GMP certifications for cell therapy production facilities
      • 5.1.1.3. Surge in government initiatives through investments in cell-based research
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with cell therapy technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing focus on personalized medicine
      • 5.1.3.2. Emergence of iPSCs as an alternative to ESCs in technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals and stringent regulatory framework
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: The advent of big data analytics tools driving the adoption of software tools for cell therapies
    • 5.2.2. Process: Advancements in cell preservation technologies
    • 5.2.3. Cell type: Rising utilization of human cells in cell and gene therapies
    • 5.2.4. End user: Government initiatives to propel investments in research institutes
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cell Therapy Technologies Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment
  • 6.4. Software

7. Cell Therapy Technologies Market, by Process

  • 7.1. Introduction
  • 7.2. Cell Preservation, Distribution, & Handling
  • 7.3. Cell Processing
  • 7.4. Process Monitoring & Quality Control

8. Cell Therapy Technologies Market, by Cell Type

  • 8.1. Introduction
  • 8.2. Animal Cells
  • 8.3. Human Cells

9. Cell Therapy Technologies Market, by End-User

  • 9.1. Introduction
  • 9.2. Healthcare & Life Science
  • 9.3. Research Institutes

10. Americas Cell Therapy Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Therapy Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Therapy Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Clade Therapeutics Announces the Acquisition of Gadeta B.V.
    • 13.3.2. Startup Cellares adds USD 255 million as investors pour cash into cell therapy production
    • 13.3.3. NewBiologix Launches with USD 50 million to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CELL THERAPY TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. CELL THERAPY TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CELL THERAPY TECHNOLOGIES MARKET DYNAMICS
  • FIGURE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CELL THERAPY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CELL THERAPY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL THERAPY TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SINGLE-USE EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SINGLE-USE EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PRESERVATION, DISTRIBUTION, & HANDLING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PRESERVATION, DISTRIBUTION, & HANDLING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS MONITORING & QUALITY CONTROL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS MONITORING & QUALITY CONTROL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HEALTHCARE & LIFE SCIENCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HEALTHCARE & LIFE SCIENCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 151. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 152. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 176. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 188. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 200. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 201. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 202. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 210. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 212. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 214. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 218. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 224. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 225. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 226. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 227. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 230. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 236. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 248. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 249. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 250. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 251. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 254. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 260. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 261. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 262. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 263. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 266. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 272. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 273. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 274. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 275. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 278. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 295. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 296. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 297. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 298. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 299. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 300. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 301. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 304. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 305. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 310. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 311. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 312. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 313. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 316. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 317. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 318. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 319. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 320. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 321. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 322. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 323. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 324. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 325. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 328. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 329. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 330. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 331. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 332. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 333. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 334. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)

TABLE 33